Constance A. Mara

Dr. Constance A. Mara

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in The Joint Commission Journal on Quality and Patient Safety
Verified
Journal Article
Closed access
WGWendy E. Gerhardt
Wendy E. Gerhardt
CMConstance A. Mara
Constance A. Mara
IKIan Kudel
Ian Kudel
EMEsi M. Morgan
Esi M. Morgan
PSPamela J. Schoettker
Pamela J. Schoettker
EAEvaline A. Alessandrini
Evaline A. Alessandrini

18 February 2021 in Journal of Pediatric Psychology
Verified
Journal Article
Closed access
PDF file
CMConstance A. Mara
Constance A. Mara
ACAdam C Carle
Adam C Carle
This article guides researchers through the process of specifying, troubleshooting, evaluating, and interpreting latent growth mixture models. Latent growth mixture models are conducted with small example dataset of N = 117 pediatric patients using Mplus software. The example and data show how to select a solution, here a 3-class solution. We also present information on two methods for incorporating covariates into these models. Many studies in pediatric psychology seek to understand how an outcome changes over time. Mixed models or latent growth models estimate a single average trajectory estimate and an overall estimate of the individual variability, but this may mask other patterns of change shared by some participants. Unexplored variation in longitudinal data means that researchers can miss critical information about the trajectories of subgroups of individuals that could have important clinical implications about how one assess, treats, and manages subsets of individuals. Latent growth mixture modeling is a method for uncovering subgroups (or “classes”) of individuals with shared trajectories that differ from the average trajectory.

26 September 2020 in Journal of Pediatric Psychology
Verified
Journal Article
Open access
PDF file
CMConstance A. Mara
Constance A. Mara
JPJames L Peugh
James L Peugh
The COVID-19 pandemic and efforts to mitigate the spread and impact of the virus have drastically altered day-to-day operations of research trials. In the United States, widespread “lockdowns” or “stay at home” orders have halted research operations at many institutions. In some cases, institutions have halted in-person visits that are not of medical necessity. This has left many randomized behavioral clinical trials in unprecedented positions.

1 May 2017 in Journal of Pediatric Nursing
Verified
Journal Article
Closed access
HTHeather L. Tubbs-Cooley
Heather L. Tubbs-Cooley
RPRita H. Pickler
Rita H. Pickler
CMConstance A. Mara
Constance A. Mara
MOMohammad Othman
Mohammad Othman
AKAllison Kovacs
Allison Kovacs
BMBarbara A. Mark
Barbara A. Mark

22 March 2022 in Child Abuse & Neglect
Verified
Journal Article
Closed access
SBSarah Beal
Sarah Beal
RARobert T. Ammerman
Robert T. Ammerman
CMConstance A. Mara
Constance A. Mara
KNKatie Nause
Katie Nause
MGMary V. Greiner
Mary V. Greiner

26 April 2020 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
OHOnengiya Harry
Onengiya Harry
LCLori E. Crosby
Lori E. Crosby
CMConstance A. Mara
Constance A. Mara
TTTracy V. Ting
Tracy V. Ting
JHJennifer L. Huggins
Jennifer L. Huggins
AMAvani Modi
Avani Modi
Background: In Childhood-Onset Systemic Lupus Erythematosus (cSLE), poor medication adherence rates are very high. Interventions targeting this problem in cSLE are limited thus effective interventions are needed. The objective of this study is to examine the feasibility and acceptability an intervention (automated digital reminders + personalized prescribed treatment plan (pPTP)) to improve medication adherence in young adults with cSLE over 3 months. Method: This is a proof-of-concept randomized controlled study. All participants received SimpleMed+ pillboxes that track adherence. The treatment group received a pPTP, and in month 2, preselected digital reminders for missed doses. Reminders were discontinued after 30 days and adherence data collected. Data analysis was done using t-tests. Results: Twenty-one participants were approached and nineteen consented to participate, yielding a recruitment rate of 86%. Participants were on average 20.5 years, mostly black (58%) and female (84%). Of the nineteen consented, eleven were randomized to control (57%) and eight to treatment (42%) groups respectively. All participants in the treatment group rated the pillbox as easy to use, notably; none reported boredom with the pillbox or reminders. Also, 88% of participants in the treatment group rated the pillbox as helpful, however, only 50% reported the pPTP taught them new information about lupus or made them more interested in their lupus management. Conclusions: This is the first use of an electronic pillbox to track adherence to multiple medications in cSLE. The high rating of the pillbox makes it an acceptable method of measuring adherence. Feasibility and acceptability ratings for the intervention were mixed suggesting a there is a subset of cSLE patients for whom this intervention would be beneficial. Future research should focus on a larger trial.